Medicine & Life Sciences
Prostatic Neoplasms
100%
Urinary Bladder Neoplasms
77%
talimogene laherparepvec
69%
Castration
60%
Ipilimumab
55%
Network Meta-Analysis
50%
Drug Therapy
45%
atezolizumab
42%
Therapeutics
38%
pembrolizumab
38%
Systematic Reviews
37%
Melanoma
31%
Neoplasms
30%
Muscles
30%
Renal Cell Carcinoma
29%
cabozantinib
29%
Safety
28%
Prostate-Specific Antigen
27%
Carcinoma
26%
alpha-ethoxy-4-(2-(2-methyl-5-(4-methylthio)phenyl))-1H-pyrrol-1-yl)ethoxy))benzenepropanoic acid
26%
2-hydroxymethyl-2-methoxymethylazabicyclo(2.2.2)octan-3-one
25%
PROSTVAC
24%
Survival
24%
abiraterone
23%
Cisplatin
23%
MDV 3100
22%
Radium-223
20%
Cystectomy
20%
Confidence Intervals
20%
Urinary Bladder
19%
Progression-Free Survival
18%
Myocardial Infarction
18%
Cardiovascular Diseases
18%
Glomus Tumor
18%
Vena Cava Filters
17%
Thiazides
17%
Inferior Wall Myocardial Infarction
17%
Deep Learning
17%
Neoplasm Metastasis
17%
Incidence
16%
Thrombotic Thrombocytopenic Purpura
16%
Clinical Trials
16%
Immunotherapy
16%
Minority Groups
16%
Kidney Neoplasms
16%
Androgens
16%
Hemochromatosis
15%
Bone Neoplasms
15%
Iron Overload
15%
Gene Dosage
15%